Pharm Plan Minutes 2018.10.18

Minutes

Attendees

• Leonidas Tzimis
• Marc Robberecht
• Jacqueline Surugue
• Stephane Spahni
• Jurrian van der Werf
• Esther Peelen
• Jose Costa Teixeira
• Michael Tan*

• Planning of F2F in Vienna in 2019 will be difficult because Juergen cannot attend.
• Review possibilities of organizing the meeting on February 25 2019 in Rotterdam
• Action Michael.

9:00 -10:30 Adverse Event Reporting

• NWI planning en schedule
• Use case and input.
  • see chart Michael
  • anonimous: Not in Greece. Drug is also identified.
  • Lareb uses pseudoniem between hospital and National body.
  • patients also have the possibility to report adverse events directly to the regional or national body.
  • This also could be direct through the hospital or primary care.
• distinction between spontaneous reporting (10.000) and the reporting in the care process.(1000).
  • in the latter you can collect data which is already registered in the process.
• Discussion of the starting point of the ADR. It could be just an incident. At a certain point a drug is suspected.
• In our profile we would start where suspicion is focussed on a drug.
• In the definition of Lareb the ADR is defined by intervention of the care provider in the drug therapy.
• Hospitals want to collect all adverse events, not only for pharmaco vigilance, but also of knowledge growth of the drug. Examples of off label drugs. Medication errors must also be reported. 20% chance. These should also be reported to the regional or national bodies.
• In the report the care provider will not only report the suspected drug, but they put in the decursus. At the moment they have to look into 2 places. The decursus ( which is free text) and the adverse events reports.

• • Yellow card is for drugs, white card is for devices.
• Status of FHIR resource
• set the scope of of the workitem without trespassing domains of PCC and QRPH.

11:00- 12:30 Adverse Event Reporting

• Define work items and next steps.
• Work on Technical Supplement

14:00 - 15:30 Medication Information Sharing

This includes the IDMP, Medication knowledge and supporting HL7 resources. Question form International Board to think about IDMP. Understanding the influence of IDMP

15:45 - 17:00 Supply topics

Status update Plans to pick up supply . including planning. Scope. Priorities. Project members.

17:00 - Adjourn

Pharmacy Technical Committee